Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Graft-versus-host disease | R-HSA-1643685 | map05332 | eticlopride | 4993 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | eticlopride | 4993 | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | eticlopride | 4993 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | eticlopride | 4993 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | eticlopride | 4993 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | eticlopride | 4993 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | eticlopride | 4993 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | eticlopride | 4993 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | eticlopride | 4993 | drug-path |
| Vibrio cholerae infection | R-HSA-9609646 | map05110 | eticlopride | 4993 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | eticlopride | 4993 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | eticlopride | 4993 | drug-path |
| Melanogenesis | R-HSA-5662702 | map04916 | eticlopride | 4993 | drug-path |
| Glioma | Q9NZM4 | map05214 | eticlopride | 4993 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | eticlopride | 4993 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | eticlopride | 4993 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | eticlopride | 4993 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | eticlopride | 4993 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | eticlopride | 4993 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | eticlopride | 4993 | drug-path |